Thursday, February 21, 2013- Steer Clear Of Optimer's Short And Long-Term Risksat Seeking Alpha (Thu, Feb 21)
- Is AbbVie Wasting Your Money?at Motley Fool (Thu, Feb 21)
- Abbott to work with J&J on genetic test for leukemia drugat Reuters (Thu, Feb 21)
- Merck: The Most Undervalued Company In Pharmaat Seeking Alpha (Thu, Feb 21)
- The Better Way To Play Drug Makersat Motley Fool (Thu, Feb 21)
- Astellas Needs To Pick A Model To Prosperat Seeking Alpha (Thu, Feb 21)
- Will an Empty Marlins Park Create Backlash Against Sports Stadium Subsidies?at Forbes (Thu, Feb 21)
- Zoetis Provides Ample Investment Opportunity For Pfizer Followersat Seeking Alpha (Thu, Feb 21)
- Top-Line Data Show Lyrica Met Primary Endpoint in Clinical Trial as Adjunctive Therapy versus Levetiracetam in Patients with Partial Onset SeizuresBusiness Wire (Thu, Feb 21)
- Recognizing Leadership In Biotech: A Critical Facet Of The Diligence Processat Seeking Alpha (Thu, Feb 21)
Wednesday, February 20, 2013- Merck's Low Cholesterolat Motley Fool (Wed, Feb 20)
- Agilent Unit Receives FDA ApprovalZacks (Wed, Feb 20)
- Studies Examine Novel Use For New Oral Anticoagulant Drugsat Forbes (Wed, Feb 20)
- Has Johnson & Johnson Become the Perfect Stock?at Motley Fool (Wed, Feb 20)
- GSK's HIV Drug Gets Priority ReviewZacks (Wed, Feb 20)
- Launch at Novo NordiskZacks (Wed, Feb 20)
- 4 Ways to Play Our Love for Man's Best Friendat Motley Fool (Wed, Feb 20)
- March Action Date for UTHR CandidateZacks (Wed, Feb 20)
- Which of These Top 5 Pharma Stocks Have the Strongest Earnings Trends?at Wall St. Cheat Sheet (Wed, Feb 20)
- Is Eli Lilly Being Wise About YZ?at Motley Fool (Wed, Feb 20)
- 5 Health Care Stocks Triggering 'Buys' This Weekat TheStreet (Wed, Feb 20)
Tuesday, February 19, 2013Add PFE News to My Yahoo!   | |
|
0.29(0.99%) May 17, 4:00PM EDT|After Hours
:
28.99